Expression of somatostatin receptors 1 and 2 in human choroid plexus and arachnoid granulations: Implications for idiopathic intracranial hypertension

Archives of Ophthalmology

Volumn 120, Issue 11, 2002, Pages 1540-1543

  Katz, Steven E ^a,b,e   Klisovic, Dino D ^a   O'Dorisio, M Sue ^c,d   Lynch, Richard ^c   Lubow, Martin ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^e 5717 University Hospitals Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARACHNOID; ARTICLE; CEREBROSPINAL FLUID; CHOROID PLEXUS; CLINICAL ARTICLE; EYE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACRANIAL HYPERTENSION; KIDNEY; LATERAL BRAIN VENTRICLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SUPERIOR SAGITTAL SINUS;

EID: 0036875297     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.120.11.1540     Document Type: Article

References (32)

1. Speake T, Whitwell C, Kajita H, Majid A, Brown PD. Mechanisms of CSF secretion by the choroid plexus. Microsc Res Tech. 2001;52:49-59.
2. Chodobski A, Szmydynger-Chodobska J. Choroid plexus: target for polypeptides and site of their synthesis. Microsc Res Tech. 2001;52:65-82.
3. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol. 1999;20: 157-198.
4. Relsine T, Bell GI. Molecular properties of somatostatin receptors. Neuroscience. 1995;67:777-790.
5. Vora JP, Owens DR, Ryder R, Atiea J, Luzio S, Hayes TM. Effect of somatostatin on renal function. BMJ. 1986;292:1701-1702.
6. Bausher LP, Horio B. Regulation of cyclic AMP production in adult human ciliary processes. Exp Eye Res. 1995;60:43-48.
7. Tulassay T, Tulassay Z, Rascher W, Szucs L, Seyberth HW, Nagy I. Effect of somatostatin on kidney function and vasoactive hormone systems in healthy subjects. Klin Wochenschr. 1991;69:486-490.
8. Wax MB, Barret DA. Regulation of adenylyl cyclase in rabbit iris ciliary body. Curr Eye Res. 1993;12:507-520.
9. 2+ produced by somatostatin and acetylcholine in ciliary body epithelial cells. Exp Eye Res. 1997;64: 627-635.
10. Balster DA, O'Dorisio MS, Summers MA, Turman MA. Segmental expression of somatostatin receptor subtypes sst(1) and sst(2) in tubules and glomeruli of human kidney. Am J Physiol Renal Physiol. 2001;280:F457-F465.
11. Antaraki A, Piadites G, Vergados J, Andreou A, Chlouverakis C. Octreotide in benign intracranial hypertension [letter]. Lancet. 1993;342:1170.
12. Albers AR, O'Dorisio MS, Balster DA, et al. Somatostatin receptor gene expression in neuroblastoma. Regul Pept. 2000;88:61-73.
13. Klisovic DD, O'Dorisio MS, Katz SE, et al. Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study. Invest Ophthalmol Vis Sci. 2001;42:2193-2201.
14. Thoss VS, Piwko C, Probst A, Hoyer D. Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary. Naunyn Schmiedebergs Arch Pharmacol. 1997;355:168-176.
15. Brazeau P, Vale W, Burgus R, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973;179:77-79.
16. Otten BJ, Roettvel JJ, Cruysberg JRM. Pseudotumor cerebri following treatment with growth hormone [abstract]. Horm Res. 1992;37:16.
17. Malozowski S, Tanner LA, Wysowski DK, Fleming GA. Growth hormone, insulin-like growth factor I, and benign intracranial hypertension. N Engl J Med. 1993; 329:665-666.
18. Lordereau-Richard I, Roger M, Chaussain JL. Transient bilateral papilloedema in a 10-year-old boy treated with recombinant insulin-like growth factor I for growth hormone receptor deficiency. Acta Pediatr Suppl. 1994;399:152.
19. Guevara-Aguirre J, Vasconez O, Martinez V, et al. A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. J Clin Endocrinol Metab. 1995;80:1393-1398.
20. Malozowski S, Tanner LA, Wysowski DK, Fleming GA, Stadel BV. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr. 1995;126:996-999.
21. Price DA, Clayton PE, Loyd IC. Benign intracranial hypertension induced by growth hormone treatment. Lancet. 1995;345:458-459.
22. Wingenfeld P, Schmidt B, Hoppe B, et al. Acute glaucoma and intracranial hypertension in a child on long-term peritoneal dialysis treated with growth hormone. Pediatr Nephrol. 1995;9:742-745.
23. Francois I, Casteels I, Silberstein J, Casaer P, de Zegher F. Empty sella, growth hormone deficiency and pseudotumour cerebri: effect of initiation, withdrawal and resumption of growth hormone therapy. Eur J Pediatr. 1997;156:69-70.
24. Koller EA, Stadel BV, Malozowski SN. Papilledema in 15 renally compromised patients treated with growth hormone. Pediatr Nephrol. 1997;11:451-454.
25. Azcona C, Preece MA, Rose SJ, et al. Growth response to rbIGF-I 80 μg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype. Clin Endocr (Oxf). 1999;51:787-792.
26. Rogers AH, Rogers GL, Bremer DL, McGregor ML. Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology. 1999;106: 1186-1190.
27. Lai ZN, Emtner M, Roos P, Nyberg F. Characterization of putative growth hormone receptors in human choroid plexus. Brain Res. 1991;546:222-226.
28. De Keyser J, Wilczak N, De Backer JP, Herroelen L, Vaquelin G. Insulin-like growth factor-I receptors in human brain and pituitary gland: an autoradiographic study. Synapse. 1994;17:196-202.
29. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H. Free insulin-like growth factors in human obesity. Metabolism. 1995;44(10, suppl 4):37-44.
30. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjests: the impact of type 2 diabetes. Diabetes Metab Res Rev. 1999;15:314-322.
31. Nam SY, Marcus C. Growth hormone and adipocyte function in obesity. Horm Res. 2000;53(suppl 1):87-97.
32. Klisovic DD, Sall JW, O'Dorisio MS, Katz SE. Somatostatin and octreotide inhibit IGF-1 mediated IGF-1Rb phosphorylation in human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2001;42:244.